Accurins: Next Generation Targeted Cancer Therapeutics
Sr. Vice President, Technology, Research and Development
Prior to joining BIND Biosciences, Dr. Hrkach was Senior Director of Drug Delivery and Strategic Product Development at Momenta Pharmaceuticals, serving as program leader for the Drug Delivery and generic COPAXONE programs and as Alliance Manager for the Sandoz/Novartis collaboration. Prior to Momenta, Dr. Hrkach was Director of Pulmonary Formulations at Alkermes, focusing on the AIR large porous particle technology development programs. Dr. Hrkach joined AIR at its inception in 1998 following his postdoctoral research with Professor Robert Langer at MIT. Dr. Hrkach has over 25 scientific publications and 25 patents/applications in drug delivery and polymer chemistry. He received his Ph.D. in Chemistry and M.S. in Polymer Science from Carnegie Mellon University and his B.S. in Chemistry from the Philadelphia College of Pharmacy and Science.